News & Events

AUTM ASIA 2019

4-7 November 2019
AUTM ASIA 2019 is your chance to learn from the best international tech transfer professionals around the globe! You will gain valuable insights from international government, academic and industry sectors which will highlight the basic principles of tech transfer as well as explore the monumental changes occurring the tech transfer eco system today.
AUTM ASIA 2019 will showcase powerful stories at the intersection of invention, innovation and commercialization to provide valuable expertise and know-how to navigate the next era of tech transfer.

Wohl Institute for Translational Medicine Inaugurated at Hadassah Medical Organization in Jerusalem

29 October 2019
Applied Research for Personalized Medicine The Wohl Institute offers state-of-the-art imaging technologies for preclinical research The research at the Wohl Institute will promote the development of dedicated medications and treatments.

Allied Corp., a Medical Cannabis Company, signs Master Services Agreement with Carmel

28 October 2019
Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, has entered into a Master Services Agreement with the University of Haifa, Israel via their wholly owned commercialization subsidiary: Carmel - Haifa University Economic Corporation Ltd. (“Haifa”).

AI Peptide Startup Pepticom Raises $5 Million

24 October 2019
Jerusalem-based Pepticom Ltd. has raised $5 million in a series A funding round, the company announced Thursday. Founded in 2011, Pepticom uses artificial intelligence algorithms to design peptide drug candidates based on the known structure of the required target proteins.

ITTN Annual PDF Report 2018

12 August 2019
The Israel Tech Transfer Network, ITTN, is pleased to present its first annual report. In 2018, the 166 technology transfer professionals acting for ITTN’s 15 members produced a remarkable deal flow and over 1,000 new patent disclosures.
ITTN’s mission is to maintain and enhance our members’ contribution by developing our professional capacities, generating novel best practices, formulating new collaborations, and building dialogue with our partners in industry and government.

Brief Yeshiva University Launches Joint New York Innovation Lab, With Hebrew University as Strategic Partner

21 May 2019
The lab, located on Yeshiva University’s campus, will help Israeli startups looking to expand to the U.S. market make connections within New York’s tech and business environment

Yissum Announces New Platform for 3D Printing of Personalized Medicine

6 November 2018
Yissum, the Technology Transfer Company of The Hebrew University announced a novel technology for the 3D printing of drug capsules. The technology is based on custom-printed 3D hydrogels with delayed release characteristics. The technology will be presented at the 2nd annual conference, 3d Printing and Beyond, November 7, 2018, at the Hebrew University in Jerusalem.

ITTN - The 5th Biennial Conference

22-24 October 2018
Israeli TTOs are leading the tech transfer transformation with more revenue from IP sales than any other country except the U.S. ITTN’s 5th biennial conference will showcase the changes occurring in Israel’s tech transfer environment such as: Israel’s integrated approach to tech transfer.
Facilitating the relationships and the free transfer of ideas between academia and entrepreneurs, investors, industry and community. The fast deal making approach employed by Israeli universities today. The event includes the biennial conference day, multiple workshops by leaders in the field, as well as tours of some of the most active and innovative tech hubs in Israel.

Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug

17 July 2018
PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent

Tyson Foods Backs Israeli Startup to Grow Meat in the Lab

2 May 2018
Future Meat Technologies focuses on producing fat and muscle cells that are the core building blocks of meat, and is one of several firms working on technology to match rising demand for meat without adding more pressure on land from livestock.